Dupixent (dupilumab) - Sanofi, Regeneron
Caregiver-Reported Eosinophilic Esophagitis Symptoms Improve In Children Aged 1–11 Years Receiving Dupilumab (ACAAI 2026) - Oct 28, 2026 - Abstract #R307; Pres time: Nov 15, 2026; 11:45 AM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 22; No abstract available 
Clinical • Eosinophilic Esophagitis • Gastrointestinal Disorder • Immunology
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Next